INDIA GLYCOLS LTD.

India Glycols Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with the company's Code of Conduct for Regulating, Monitoring and Reporting Trading in Securities. The trading window will remain shut from Thursday, October 1, 2026, until 48 hours after the declaration of the financial results for the quarter and half-year ending September 30, 2026. This measure is standard practice to prevent insider trading during sensitive financial reporting periods. The information is also available on the company's website.

India Glycols Limited has announced a plant visit for investors and analysts scheduled for September 19th and 20th, 2026. The visit will include interactions with participants and will cover plant locations in Kashipur and Dehradun. The company has stated that discussions will be based on publicly available information, and no unpublished price-sensitive information (UPSI) will be disclosed. This announcement is also being hosted on the company's website.

India Glycols Ltd announced a significant corporate action following a Board of Directors meeting on September 8, 2026. The company approved the allotment of 2,23,42,255 fully paid-up equity shares of INR 5 each in a 1:3 ratio to eligible shareholders as per the Scheme of Arrangement. The record date for this allotment was September 2, 2026. Additionally, the Board appointed Shri Ajay Sharma as Chief Financial Officer & Key Managerial Personnel and Smt. Preeti Choudhary as Company Secretary, Key Managerial Personnel & Compliance Officer. The company also approved the appointment of M/s Mukesh Agarwal & Co. as Secretarial Auditor for FY 2026-27 to 2030-31 and M/s S.S. Kothari Mehta & CO. LLP as Internal Auditor for FY 2026-27. An Information Memorandum for listing and trading approval of the allotted shares was also approved.

India Glycols Limited announced a significant corporate action following its Board Meeting on September 8, 2026. The company approved the allotment of 6,70,26,765 equity shares of INR 5 each, on a 1:1 ratio, to eligible shareholders as part of a Scheme of Arrangement. This allotment ranks pari passu with existing shares. Additionally, the Board appointed Naresh Kumar Agrawal as Chief Financial Officer and Ishan Khanna as Company Secretary. M/s MAKS & Co. was appointed Secretarial Auditor for five years, and M/s S.S. Kothari Mehta & CO. LLP as Internal Auditor for FY 2026-27. The company will also seek stock exchange approval for listing these new shares.

India Glycols Ltd has announced the resignation of three Non-Executive Directors: Shri Manish Chandra Pant, Shri Bhupendar Pal Singhal, and Shri Shashi Kant Shukla. The resignations are effective immediately, as of September 7, 2026, and are stated to be due to personal reasons. The company has provided the necessary details as required by SEBI Master Circulars. This announcement is made in connection with updates from its subsidiary, Ennature Bio Pharma Limited, and in relation to observation letters from NSE and BSE concerning a Scheme of Arrangement.

India Glycols Ltd has announced the resignation of three Non-Executive Directors: Shri Manish Chandra Pant, Shri Bhupendar Pal Singhal, and Shri Shashi Kant Shukla, from the company with immediate effect. The resignations are stated to be due to personal reasons and are effective from September 7, 2026. This update is in connection with IGL Spirits Limited and follows observation letters from NSE and BSE regarding a Scheme of Arrangement. The company has provided details of the directors' resignations as per SEBI Master Circular requirements.

India Glycols Ltd has announced that certain Senior Managerial Personnel (SMP) have ceased to be SMPs of the company effective close of business hours on August 31, 2026. This follows the transfer of their employment to the resulting companies, as per the Scheme of Arrangement which became effective on September 1, 2026. The company has provided details of the affected personnel, including their names and designations, and the reason for their cessation as SMPs. This update is in line with SEBI Listing Regulations and the company's website will also host this information.

India Glycols Limited has successfully demerged into three separate entities: India Glycols Limited (chemicals, glycols, bio-glycols, specialty products, industrial gases), IGL Spirits Limited (spirits, IMFL, country liquor, bio-fuel), and Ennature Bio Pharma Limited (bio-pharma, bio-polymers). The demerger, effective September 1, 2026, was sanctioned by the NCLT and the order has been filed with the Registrar of Companies. Shareholders as of September 2, 2026, will receive shares in the new entities. This move aims to create focused businesses, enabling better management oversight, resource allocation, and capital utilization for each entity.

India Glycols Limited announced board resolutions approving the appointment of Ms. Pragya Bhartia Barwale as Managing Director for five years, subject to shareholder approval. Additionally, Mr. U.S. Bhartia, Ms. Pooja Jhaver, Mr. Malay Memani, Ms. Shukla Wassan, Ms. Bharati Agarwal, and Ms. Shilpa Divakar Nirula were appointed as Additional Directors, with Mr. Memani, Ms. Wassan, Ms. Agarwal, and Ms. Nirula designated as Independent Directors for three-year terms. These appointments are effective August 21, 2026, and are subject to shareholder consent. The company also provided an update regarding Ennature Bio Pharma Limited, enclosing material events as Annexure A, in line with stock exchange observation letters and SEBI regulations.

India Glycols Limited (IGL) has announced significant board-level changes following a meeting on August 21, 2026. The company's Board of Directors has approved the appointment of several new directors and Key Managerial Personnel (KMP). Shri U.S. Bhartia has been appointed as Chairman and Managing Director for a five-year term, subject to shareholder approval. Additionally, Shri Vedant Jhaver, Shri Shirish Rajendra Barwale, Shri Samrat Banerjee, Shri Raj Kishore Singh, Shri Vimal Bhandari, and Ms. Nidhi Jagat Killawala have been appointed as Additional Directors, with some designated as Independent Directors for three-year terms. These appointments are subject to shareholder consent and are affirmed to comply with SEBI regulations regarding directorships. The filing also references material updates concerning IGL Spirits Limited (IGSL), enclosed as Annexure A, in relation to a Scheme of Arrangement.